Report overview
The global Clinical Absorbable Hemostat market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Hemostatic Gauze Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Clinical Absorbable Hemostat include Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences and Zhonghui Shengxi, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Absorbable hemostatic material is a kind of biomedical material that can be used to stop bleeding quickly and be absorbed by the human body within a certain period of time.
This report aims to provide a comprehensive presentation of the global market for Clinical Absorbable Hemostat, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Absorbable Hemostat. This report contains market size and forecasts of Clinical Absorbable Hemostat in global, including the following market information:
Global Clinical Absorbable Hemostat Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Clinical Absorbable Hemostat Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Clinical Absorbable Hemostat companies in 2023 (%)
We surveyed the Clinical Absorbable Hemostat manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical Absorbable Hemostat Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Clinical Absorbable Hemostat Market Segment Percentages, by Type, 2023 (%)
Hemostatic Gauze
Styptic Powder
Gelatin
Other
Global Clinical Absorbable Hemostat Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Clinical Absorbable Hemostat Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Other
Global Clinical Absorbable Hemostat Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Clinical Absorbable Hemostat Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical Absorbable Hemostat revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Clinical Absorbable Hemostat revenues share in global market, 2023 (%)
Key companies Clinical Absorbable Hemostat sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Clinical Absorbable Hemostat sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products
Outline of Major Chapters:
Chapter 1: Introduces the definition of Clinical Absorbable Hemostat, market overview.
Chapter 2: Global Clinical Absorbable Hemostat market size in revenue and volume.
Chapter 3: Detailed analysis of Clinical Absorbable Hemostat manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Clinical Absorbable Hemostat in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Clinical Absorbable Hemostat capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
